In vitro studies on the effects of cryopreserved platelet-rich plasma on cells related to wound healing
Rui SuLei SunYu-Fan DingZhao PanFei-Yu YangHui FangXiao-Yu LiaoLiang DongHui-Qin Wen1 Department of Blood Transfusion,The First Affiliated Hospital of Anhui Medical University,Hefei,China2 Zhejiang Cancer Hospital,Hangzhou Institute of Medicine (HIM),Chinese Academy of Sciences,Hangzhou,Zhejiang,China3 College & Hospital of Stomatology,Key Laboratory of Oral Diseases Research of Anhui Province,Anhui Medical University,Hefei,China
DOI: https://doi.org/10.1080/09537104.2024.2347331
2024-05-09
Platelets
Abstract:Platelet-rich plasma (PRP) holds promise as a therapeutic modality for wound healing; however, immediate utilization encounters challenges related to volume, concentration, and consistency. Cryopreservation emerges as a viable solution, preserving PRP's bioactive components and extending its shelf life. This study explores the practicality and efficacy of cryopreserved platelet-rich plasma (cPRP) in wound healing, scrutinizing both cellular mechanisms and clinical implications. Fresh PRP and cPRP post freeze-thaw underwent assessment in macrophage, fibroblast, and endothelial cell cultures. The impact of cPRP on active component release and cell behavior pertinent to wound healing was evaluated. Varied concentrations of cPRP (1%, 5%, 10%) were examined for their influence on cell polarization, migration, and proliferation. The results showed minimal changes in cPRP's IL-1β levels, a slight decrease in PDGF-BB, and superior effects on macrophage M2 polarization and fibroblast migration, while no statistical significance was observed in endothelial cell angiogenesis and proliferation. Remarkably, 5% PRP exhibited the most significant stimulation among all cPRP concentrations, notably impacting cell proliferation, angiogenesis, and migration. The discussion underscores that cPRP maintains platelet phenotype and function over extended periods, with 5% cPRP offering the most favorable outcomes, providing a pragmatic approach for cold storage to extend post-thaw viability and amplify therapeutic effects. What is the context? What is new? What is the impact?
cell biology,hematology
What problem does this paper attempt to address?